We’ll begin with a study that focused on elevations in cancer incidence among responders to the World Trade Center site after the September 11, 2001 terrorist attacks. We’ll then turn to an analysis evaluating the effect of proton pump inhibitor use on decreased cognitive functioning among breast cancer survivors. Lastly, we’ll look at a trial that compared detection and grading of prostate cancer with a novel artificial intelligence system vs seasoned experts.

Coverage of stories discussed this week on ascopost.com: 

Cancer Incidence in World Trade Center Responders to the September 11 Attacks

Does Proton Pump Inhibitor Use Affect Cognition in Breast Cancer Survivors?

Use of Artificial Intelligence for Diagnosing and Grading Prostate Cancer